Principal Securities’s Alpine Immune Sciences Inc ALPN Stock Holding History

Principal Securities’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-6	Closed	-$238	–	3498
2024 Q1	$238	Buy	+6	New	+$177	﹤0.01%	3225

Principal Securities's ALPN Position: Q2 2024 in Review

Principal Securities sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 6 shares — an estimated $238 sold.

Principal Securities first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $238 in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Principal Securities reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Principal Securities sold 6 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $238.
Principal Securities first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Principal Securities's Alpine Immune Sciences Inc position peaked at $238 in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Principal Securities's 13F filing for Q2 2024, filed 31 Jul 2024.